Steven L. Hoerter Insider Trading $AGIO AGIOS PHARMACEUTICALS, INC.
Get free email notifications about insider trading for Steven L. Hoerter.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Steven L. Hoerter. Steven L. Hoerter is in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Director in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Chief Commercial Officer in AGIOS PHARMACEUTICALS INC ($AGIO) and SEE REMARKS in Clovis Oncology, Inc. ($CLVS) and Director in Ignyta, Inc. ($RXDX) and Director in Deciphera Pharmaceuticals, Inc. ($DCPH) and President & CEO in Deciphera Pharmaceuticals, Inc. ($DCPH) and President and CEO in Deciphera Pharmaceuticals, Inc. ($DCPH).
Steven L. Hoerter in AGIOS PHARMACEUTICALS, INC.
Trading Symbol: AGIOIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Steven L. Hoerter: Chief Commercial Officer
Holdings: 11,981 shares
Current Value: $532,196
Latest Transaction: Feb 20 2019
$AGIO Market Capitalization: $1.88B
$AGIO Previous Close: $44.42
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Steven L. Hoerter in AGIOS PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGIO, CLVS, CNST, DCPH, RXDX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 0.00 | 2,750 | 0 | 5,500 | |
Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Payment of Exercise | F | 58.03 | 1,040 | 60,351 | 10,941 | 12 K to 10.9 K (-8.68 %) |
Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 0.00 | 2,750 | 0 | 11,981 | 9.2 K to 12 K (+29.79 %) |
Jan 23 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
Jan 23 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Payment of Exercise | F | 52.82 | 5,769 | 304,719 | 9,231 | 15 K to 9.2 K (-38.46 %) |
Jan 23 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
Aug 28 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 39.76 | 2,050 | 81,508 | 60,650 | |
Aug 28 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Sell | S | 74.92 | 2,050 | 153,586 | 0 | 2.1 K to 0 (-100.00 %) |
Aug 28 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 39.76 | 2,050 | 81,508 | 2,050 | 0 to 2.1 K |
Jul 27 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 39.76 | 2,050 | 81,508 | 62,700 | |
Jul 27 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Sell | S | 84.58 | 2,050 | 173,389 | 0 | 2.1 K to 0 (-100.00 %) |
Jul 27 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 39.76 | 2,050 | 81,508 | 2,050 | 0 to 2.1 K |
Jul 24 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
Jun 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 39.76 | 2,050 | 81,508 | 64,750 | |
Jun 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Sell | S | 97.58 | 2,050 | 200,039 | 0 | 2.1 K to 0 (-100.00 %) |
Jun 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 39.76 | 2,050 | 81,508 | 2,050 | 0 to 2.1 K |
May 29 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 39.76 | 2,050 | 81,508 | 66,800 | |
May 29 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Sell | S | 85.76 | 2,050 | 175,808 | 0 | 2.1 K to 0 (-100.00 %) |
May 29 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 39.76 | 2,050 | 81,508 | 2,050 | 0 to 2.1 K |
Apr 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 39.76 | 2,050 | 81,508 | 68,850 | |
Apr 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Sell | S | 85.95 | 2,050 | 176,198 | 0 | 2.1 K to 0 (-100.00 %) |
Apr 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 39.76 | 2,050 | 81,508 | 2,050 | 0 to 2.1 K |
Mar 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 39.76 | 2,050 | 81,508 | 70,900 | |
Mar 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Sell | S | 84.65 | 2,050 | 173,533 | 0 | 2.1 K to 0 (-100.00 %) |
Mar 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 39.76 | 2,050 | 81,508 | 2,050 | 0 to 2.1 K |
Feb 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 39.76 | 2,050 | 81,508 | 72,950 | |
Feb 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Sell | S | 78.63 | 2,050 | 161,192 | 0 | 2.1 K to 0 (-100.00 %) |
Feb 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 39.76 | 2,050 | 81,508 | 2,050 | 0 to 2.1 K |
Feb 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | A | 0.00 | 8,250 | 0 | 8,250 | |
Feb 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | A | 77.70 | 33,000 | 2,564,100 | 33,000 | |
Jan 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 39.76 | 25,000 | 994,000 | 75,000 | |
Jan 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Sell | S | 74.83 | 25,000 | 1,870,750 | 0 | 25 K to 0 (-100.00 %) |
Jan 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 39.76 | 25,000 | 994,000 | 25,000 | 0 to 25 K |
Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | A | 50.40 | 47,600 | 2,399,040 | 47,600 | |
Feb 18 2016 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | A | 39.76 | 100,000 | 3,976,000 | 100,000 |
Page: 1